A novel angiotensin receptor subtype in rat mesangium. Coupling to adenylyl cyclase.
نویسندگان
چکیده
The diversity of angiotensin II (Ang II) actions implies multiple receptor subtypes. To characterize these subtypes in rat mesangial cells, we used the angiotensin subtype 1A (AT1A) antagonist losartan (DuP 753), the subtype 2/1B (AT2/AT1B) antagonist PD 123319, and the AT2 antagonist CGP 42112A in radioreceptor and adenylyl cyclase assays. In radioligand binding competition experiments, approximately 25% of the specific binding sites labeled by 125I-[Sar1]Ang II were inhibited by low concentrations of PD 123319 (0.1 to 10 nM), whereas the AT2 antagonist CGP 42112A was inactive at concentrations less than 0.1 microM. Conversely, losartan inhibited 75% of the binding at low concentrations (0.1 nM to 0.1 microM), but higher concentrations (up to 10 microM) were required to inhibit the second component of 125I-[Sar1]Ang II binding. The effects of the different antagonists on the inhibition by Ang II of forskolin-stimulated cyclic AMP production were also analyzed. Ang II inhibited forskolin-stimulated adenylyl cyclase in a concentration-dependent fashion (IC50, 35 +/- 7 nM), and the maximal inhibition of adenylyl cyclase was 44 +/- 2%. In the radioligand binding experiments, both losartan and PD 123319 antagonized the inhibition of adenylyl cyclase elicited by 0.1 microM Ang II (IC50, 0.5 +/- 0.2 and 1.2 +/- 0.4 microM, respectively), whereas CGP 42112A was less potent (IC50, 5.7 +/- 1.6 microM). Comparison of binding affinities at AT1B receptor sites with antagonist potencies in the adenylyl cyclase assay show good agreement for losartan and CGP 42112A, whereas PD 123319 is less potent than expected from membrane binding assays, possibly because of partial agonist properties.(ABSTRACT TRUNCATED AT 250 WORDS)
منابع مشابه
A Novel Angiotensin Receptor Subtype in Rat Mesangium Coupling to Adenyiyi Cyclase
The diversity of angiotensin II (Ang II) actions implies multiple receptor subtypes. To characterize these subtypes in rat mesangial cells, we used the angiotensin subtype LA (ATu) antagonist losartan (DuP 753), the subtype 2/1B (AT2/AT,B) antagonist PD 123319, and the AT2 antagonist CGP 421L2A in radioreceptor and adenyiyi cyclase assays. In radioligand binding competition experiments, approxi...
متن کاملاندازهگیری فعالیت آدنیلیل سیکلاز غشاء سلولی در حضور پروتئین کموتاکسیک ماکروفاژ
Adenylyl cyclase is a membrane-bound enzyme that catalyzes the conversion of ATP to cAMP. The inhibition of adenylyl cyclase was carried out by measuring the ability of the macrophage chemotactic protein-1 to inhibit the forskolin-induced enzyme activity. Measurement of adenylyl cyclase activity was performed according to the procedure described by Wiegn. Adenylyl cyclase activity in the pres...
متن کاملTransient receptor coupling in the activation of rat liver plasma-membrane adenylate cyclase by glucagon.
متن کامل
‘Modulation of ANF-RZ/ANP-C Rccv+ors by Angiotensin II in Vascular Smoot ii Muscle Cells
In !he present studies, we have investigated the modulation of atria1 nalriuretic factor (ANF) receptor of 82 subtype (ANF-RZ) coupled to adenylyl cyclase!cAMP Fignal transduction system by angiotensir 11 (All). C-ANFIm2, I CANFI-z~,IdesfGln’R, Ser’“, Gin=, Leu”, GlyzZ)ANF,-,,-NH21 and A!1 inhibited adenylyl cyclase activity in control vascular smooth muscle cells (VSMC A-10) by about 40% and 3...
متن کاملDopamine D2 receptor inhibition of adenylyl cyclase is abolished by acute ethanol but restored after chronic ethanol exposure (tolerance).
Dopamine D2 (D2) receptors seem to mediate reinforcing responses to addicting drugs. A stably transfected NG108-15 cell line expressing the long form of the rat brain D2 receptor (D2L) was used to determine how ethanol modifies D2 receptor coupling to adenylyl cyclase. Activation of D2L receptors by the D2 receptor-specific agonist R-(-)-2,10,11-trihydroxy-N-propylnorapomorphine hydrobromide (N...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Hypertension
دوره 21 6 Pt 2 شماره
صفحات -
تاریخ انتشار 1993